awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52663213-E4289EAC-8C8A-4F7F-A39E-36E90D88131D
Q52663213-E4289EAC-8C8A-4F7F-A39E-36E90D88131D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52663213-E4289EAC-8C8A-4F7F-A39E-36E90D88131D
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes.
P2860
Q52663213-E4289EAC-8C8A-4F7F-A39E-36E90D88131D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52663213-E4289EAC-8C8A-4F7F-A39E-36E90D88131D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d8652ad2a53942ad61afd5458b34913f1727bc7
P2860
Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.